Atropine Sulfate Injection
Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 01/01/2012
- Package NDC
- 16729-525-08
- Generic name
- Atropine Sulfate Injection
- Contact info
- 866-941-7875, option 2
- Availability
- Unavailable
- Related info
- Estimated availability: December 2026
- Update date
- 11/02/2026
- Dosage form
- Injection
- Presentation
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)
- Company name
- Accord Healthcare Inc.
- Shortage reason
- Requirements related to complying with good manufacturing practices
- Status
- Current
- Therapeutic category
- Anesthesia, Neurology, Pediatric
- Harmonized identifiers (openFDA)
- Application number
- NDA214652
- Brand name
- ATROPINE SULFATE
- Generic name
- ATROPINE SULFATE
- Manufacturer name
- Accord Healthcare Inc.
- Product NDC
- 16729-525, 16729-526
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- ATROPINE SULFATE
- RxCUI
- 1190795, 1666781
- SPL ID
- 5e4be5c3-5fca-2d0e-e063-6394a90a81c1
- SPL set ID
- d5e07279-48ca-4f83-9633-299e65a7f821
- Package NDC
- 16729-525-63, 16729-525-03, 16729-525-08, 16729-526-63, 16729-526-03, 16729-526-08
- UNII
- 03J5ZE7KA5
